Ticker > Company >

Medi-Caps share price

Medi-Caps Ltd.

NSE: MEDICAPS BSE: 523144 SECTOR: Chemicals  19k   78   11

50.22
-0.32 (-0.63%)
BSE: Today, 04:00 PM

Price Summary

Today's High

₹ 51.49

Today's Low

₹ 49.51

52 Week High

₹ 63.49

52 Week Low

₹ 40.56

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

62.62 Cr.

Enterprise Value

62.58 Cr.

No. of Shares

1.25 Cr.

P/E

25.57

P/B

0.93

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  54.16

CASH

0.05 Cr.

DEBT

0 Cr.

Promoter Holding

50.43 %

EPS (TTM)

₹  1.96

Sales Growth

6966.47%

ROE

6.09 %

ROCE

7.57%

Profit Growth

1411.74 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year6966.47%
3 Year∞%
5 Year-19.82%

Profit Growth

1 Year2554.06%
3 Year233.5%
5 Year45.75%

ROE%

1 Year6.09%
3 Year2.13%
5 Year-1.34%

ROCE %

1 Year7.57%
3 Year2.64%
5 Year-1.02%

Debt/Equity

0

Price to Cash Flow

20.24

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 50.43 0.00
Jun 2024 50.13 0.00
Mar 2024 50.13 0.00
Dec 2023 50.13 0.00
Sep 2023 50.13 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company’s PEG ratio is 0.0181179865514153.
  • The company has an efficient Cash Conversion Cycle of 24.9764 days.
  • Company has a healthy liquidity position with current ratio of 18.6336.
  • The company has a high promoter holding of 50.43%.

 Limitations

  • Company has a poor ROE of 2.13059351994008% over the past 3 years.
  • Company has a poor ROCE of 2.63623197616607% over the past 3 years
  • The company has a low EBITDA margin of -58.3724033404672% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 2.13 3.05 1.97 0.29 0.98
Total Expenditure 0.16 0.87 0.93 0.69 0.59
Operating Profit 1.97 2.17 1.04 -0.4 0.39
Other Income 0 0 0.14 0.11 0.1
Interest 0 0 0 0 0
Depreciation 0.04 0.04 0.04 0.04 0.04
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.93 2.14 1.14 -0.33 0.45
Tax 0 0.45 0.49 0 0
Profit After Tax 1.93 1.69 0.65 -0.33 0.45
Adjusted EPS (Rs) 1.55 1.35 0.52 -0.27 0.36

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 10.91 0 0 0.1 7.17
Total Expenditure 19.98 0 0.56 0.39 2.33
Operating Profit -9.07 0 -0.56 -0.29 4.84
Other Income 1.12 0 0.61 0.64 0.15
Interest 0.01 0 0.01 0 0
Depreciation 0.36 0 0.09 0.09 0.16
Exceptional Items 0 0 0 0 0
Profit Before Tax -8.32 0 -0.06 0.26 4.83
Tax 0.01 -0.01 0.01 0 0.94
Net Profit -8.33 -0.11 -0.04 0.15 3.89
Adjusted EPS (Rs.) -6.68 0 -0.06 0.21 3.12

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 12.47 12.47 12.47 12.47 12.47
Total Reserves 47.38 48.5 48.82 48.64 54.02
Borrowings 0 0 0 0 0
Other N/C liabilities 0.68 0.56 0.44 0.44 0.43
Current liabilities 1.03 1.11 0.08 0.08 1.17
Total Liabilities 61.55 62.64 61.81 61.63 68.09
Assets
Net Block 3.63 3.26 2.78 2.46 2.26
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 45.47 43.02 43.91 43.91 43.91
Loans & Advances 0.05 0.05 0.05 0.05 0.05
Other N/C Assets 0 1.08 0 0 0
Current Assets 12.4 15.23 15.07 15.2 21.88
Total Assets 61.55 62.64 61.81 61.63 68.09
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -8.32 -0.12 -0.06 0.26 4.83
Adjustment 0.94 1.57 0.58 -0.28 1.65
Changes in Assets & Liabilities 6.45 0.79 -1.47 -2.57 -2.44
Tax Paid 0 0 0 0 -0.95
Operating Cash Flow -0.92 2.24 -0.95 -2.6 3.09
Investing Cash Flow -0.4 -2.19 1.01 1.85 -3.09
Financing Cash Flow -0.06 -0.06 0 0 0
Net Cash Flow -1.38 -0.02 0.06 -0.75 0

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 50.13 50.13 50.13 50.13 50.43
akshit garg - - - - 0.14
alok k garg 25.87 25.87 25.87 25.87 25.87
kusum mittal 0.08 0.08 0.08 0.08 0.10
manisha garg 21.61 21.61 21.61 21.61 21.61
nirmala mittal - - - - 0.03
palash garg - - - - 0.14
ramesh chandra mittal 0.08 0.08 0.08 0.08 0.08
trapti investments llp 2.46 2.46 2.46 2.46 2.46
nirmala mittal - - - 0.03 -
nirmala anantram mittal 0.03 0.03 0.03 - -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 49.87 49.87 49.87 49.87 49.57
dheeraj kumar lohia 2.55 3.35 3.44 4.22 4.79
investor education and pr... 0.65 - - 0.65 0.65
sangeetha s 5.57 5.57 5.57 5.57 5.57
sonal lohia - - - 1.40 1.43
investor education and pr... - 0.65 0.65 - -
punit kumar jain 1.01 1.01 - - -
gopal krishna maheshwari 1.01 - - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Medi-Caps - Quaterly Results 7 Aug, 4:17 PM Medi-Caps - Quaterly Results 7 Aug, 4:17 PM Medi-Caps - Quaterly Results 7 Aug, 4:17 PM Medi-Caps informs about disclosures 10 Jul, 3:08 PM Medi-Caps informs about compliances-certificate 6 Jul, 3:52 PM Medi-Caps - Quaterly Results 23 May, 5:53 PM Medi-Caps - Quaterly Results 23 May, 5:53 PM Medi-Caps - Quaterly Results 8 Feb, 4:54 PM Medi-Caps - Quaterly Results 8 Feb, 4:54 PM Medi-Caps - Quaterly Results 8 Feb, 4:54 PM Medi-Caps informs about certificate 9 Jan, 4:31 PM Medi-Caps informs about closure of trading window 28 Dec, 11:14 AM Medi-Caps informs about certificate 10 Oct, 2:11 PM Medi-Caps submits standalone and consolidated un-audited financial results 11 Aug, 5:08 PM Medi-Caps - Quaterly Results 11 Aug, 4:11 PM Medi-Caps - Quaterly Results 23 May, 5:12 PM Medi-Caps - Quaterly Results 23 May, 5:12 PM Medi-Caps informs about PCS certificate 21 Apr, 4:32 PM Medi-Caps informs about updates 27 Feb, 3:02 PM Medi-Caps - Quaterly Results 9 Feb, 4:28 PM Medi-Caps - Quaterly Results 9 Feb, 4:28 PM Medi-Caps - Quaterly Results 9 Feb, 4:28 PM Medi-Caps - Quaterly Results 10 Nov, 6:40 PM Medi-Caps informs about compliance certificate 7 Oct, 5:06 PM Medi-Caps informs about AGM proceedings 29 Sep, 12:32 PM Medi-Caps informs about newspaper advertisement 23 Aug, 4:51 PM Medi-Caps - Quaterly Results 4 Aug, 4:41 PM Medi-Caps - Quaterly Results 4 Aug, 4:41 PM Medi-Caps - Quaterly Results 4 Aug, 4:41 PM Medi-Caps informs about certificate 7 Jul, 5:00 PM Medi-Caps informs about newspaper advertisement 27 May, 4:35 PM Medi-Caps - Quaterly Results 25 May, 5:22 PM Medi-Caps - Quaterly Results 25 May, 5:22 PM Medi-Caps informs about disclosure 16 Apr, 3:30 PM Medi-Caps informs about compliance certificate 11 Apr, 4:25 PM Medi-Caps informs about trading window closure 30 Mar, 2:10 PM Medi-Caps informs about disclosure 25 Mar, 3:14 PM Medi-Caps informs about change in the last name of the CS cum Co 26 Feb, 4:52 PM Medi-Caps - Quaterly Results 10 Feb, 4:20 PM Medi-Caps - Quaterly Results 10 Feb, 4:20 PM Medi-Caps informs about newspaper advertisement 12 Nov, 4:18 PM Medi-Caps informs about AGM proceedings 29 Sep, 3:17 PM Medi-Caps to consider un-audited quarterly financial results 30 Jan, 12:17 PM Medi-Caps informs about press release 30 Oct, 4:41 PM

Medi-Caps Stock Price Analysis and Quick Research Report. Is Medi-Caps an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Medi-Caps stock price today is Rs 50.22. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Medi-Caps . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Medi-Caps has a PE ratio of 25.571566780386 which is high and comparatively overvalued .

  • Share Price: - The current share price of Medi-Caps is Rs 50.22. One can use valuation calculators of ticker to know if Medi-Caps share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Medi-Caps has ROA of 5.9949 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Medi-Caps has a Current ratio of 18.6336 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Medi-Caps has a ROE of 6.0945 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Medi-Caps has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Medi-Caps has reported revenue growth of 6966.4694 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Medi-Caps for the current financial year is 67.5510090155469 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Medi-Caps is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Medi-Caps is Rs 1.9639 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Medi-Caps in Ticker for free. Also, one can get the intrinsic value of Medi-Caps by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Medi-Caps
X